Trials / Completed
CompletedNCT06318117
Reason for Prescribing Rice Infant Formula
Observational Study on the Use of Infant Formulas Based on Rice Protein Hydrolysate in Real Life Conditions
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 41 (actual)
- Sponsor
- Mead Johnson Nutrition · Industry
- Sex
- All
- Age
- 6 Months – 36 Months
- Healthy volunteers
- Accepted
Summary
The main purpose of this study is to describe the pattern of RIF consumption in real life conditions, whatever the reasons of initiation and the chosen formula. The main objective is to study the reasons for prescribing a RIF during the first year of life, as per the pediatrician. Consumption started before 6 months of age, when milk and infantile formulas predominates in the baby's feeding, is of particular interest.
Detailed description
The main purpose of this study is to describe the pattern of RIF consumption in real life conditions, whatever the reasons of initiation and the chosen formula. The main objective is to study the reasons for prescribing a RIF during the first year of life, as per the pediatrician. Consumption started before 6 months of age, when milk and infantile formulas predominates in the baby's feeding, is of particular interest. Secondary objectives are to describe the modalities of feeding before, during and after consuming the RIF, to describe the growth of children who have consumed a RIF for at least 1 month, on the basis of anthropometric data collected during the first year of life. As a second intention, this study also aims to monitor the evolution of child's digestive and allergic symptoms, if any, and the sociodemographic characteristics of the infant's family.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Rice infant formula | Any commercially available rice infant formula whom the pediatrician has previously deemed, or is deeming it useful to consume. |
Timeline
- Start date
- 2024-03-12
- Primary completion
- 2025-10-31
- Completion
- 2025-12-31
- First posted
- 2024-03-19
- Last updated
- 2026-01-30
Locations
17 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06318117. Inclusion in this directory is not an endorsement.